Zolar brings soft-tissue lasers to U.S. dental market
Zolar Technology has received U.S. Food and Drug Administration clearance for the Photon and Photon Plus soft-tissue diode lasers. Zolar has already sold thousands of lasers worldwide and is now bringing its technology the U.S. market, the company noted in a press release. The new Photon (3 W of power, 810-nm wavelength) offers 21 adjustable/customizable treatment programs and four custom programs. The Photon Plus (10 W of power, 980-nm wavelength)

